News

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...
The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...
Biocon Biologics, a subsidiary of Biocon Ltd, announced on Thursday that it has received approval from the United States Food ...
Hydrogels, which are soft materials formed by cross-linking polymers, could have a variety of medical applications. In ...
A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating ...
Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.
A newly presented study has uncovered troubling molecular changes in the cervix associated with a common parasitic infection, ...
Schistosoma haematobium, responsible for urogenital schistosomiasis, affects more than 110 million people worldwide.
Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its ...
A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...
Biocon Biologics receives USFDA approval for Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for treating various ...